Delivery Order SPE2DB22D2206-SPE2DB24FJY77

Award Date 8/23/24
Potential Completion Date 9/16/24
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GAMUNEX-C 10 gram/100 ml vial in the amount of $12,022.80. The order is issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $115,417.92 firm-fixed-price contract is for the supply of GAMUNEX-C 40 gram/400 mL vials, a specialized immunoglobulin medication. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,648.20, is for the delivery of GAMUNEX-C 20 gram/200 ml vials. The contract is a firm fixed price type with a period of performance through December 19, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This $42,885.00 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of GAMUNEX-C, a 200 ML vial of immunoglobulin, to support federal healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $64,450.10 and is for the delivery of GAMUNEX-C, a 40 gram/400 ML vial immunoglobulin product, with a period of performance through February 10, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GAMUNEX-C, a 20-gram immunoglobulin product, with a ceiling value of $5,900.65 and a period of performance through June 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $55,852.80, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML medical supplies. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, a medical product used for various healthcare purposes. The contract has a firm fixed price and a ceiling value of $13,963.20, with a period of performance through April 28, 2025. This award is not set-aside and represents an open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $48,962.58 firm fixed-price delivery order is for the supply of GAMUNEX-C, a 20 gram/200 ml vial immunoglobulin product, with a performance period through August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $71,023.20, is for the delivery of GAMUNEX-C, a 5 gram/50 ml immunoglobulin product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJY77
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $48,090.80, is for the supply of GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin product. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has a firm fixed-price pricing structure and a performance period through September 16, 2024. This award does not utilize any set-aside designations.

Generated 11/22/24, 9:29 AM